semaglutide blindness risk Big headlines this past week about and due to something called NAION (nonarteritic anterior ischemic optic neuropathy). We spoke with our buddy Dr. Brugger, an ophthalmologist, all about it. Take Comparative ocular outcomes of tirzepatide

Our experienced team can help you understand your options and create a personalized plan for lasting success

h , Bar graph summarizing the effect of NMDA-induced inward current after control (aCSF, n = 5 neurons), GLP-1 (50 M, n = 5 neurons), MK-801 (50 M, n = 5 neurons) or GLP-1MK-801 (50 M, n = 5 neurons)

In another trial, retatrutide was tested in patients with treatment-naive type 2 diabetes

Increased contact time with the sublingual tissue may help with sublingual absorption

Weeks 14 Appetite suppression begins Reduced snacking Portion sizes naturally decrease Weeks 58 Steady measurable weight reduction Improved control over cravings Weeks 912 Visible physical changes Clothing fits differently For many patients, 10 pounds is achievable with consistent dosing and dietary awareness

Who Should (and Shouldn't) Take GLP-1 Medications